Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer

Gut

Volumn 61, Issue 1, 2012, Pages 135-149

  Cockbain, A J ^a   Toogood, G J ^b   Hull, Mark A ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BIOLOGICAL MARKER; CELECOXIB; CELL RECEPTOR; CORN OIL; DOCOSAHEXAENOIC ACID; FISH OIL; GEMCITABINE; GOLDEN ALGAE OIL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; MENHADEN OIL; OLEIC ACID; OMEGA 3 FATTY ACID; PACLITAXEL; PLACEBO; PROSTAGLANDIN SYNTHASE; SAFFLOWER OIL; SOYBEAN OIL; SUNFLOWER OIL; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; BLEEDING; BREAST CANCER; CELL MEMBRANE; CELL STRESS; COLON MUCOSA; COLON POLYP; COLORECTAL CANCER; DIARRHEA; DIET SUPPLEMENTATION; DISEASE MODEL; DRUG BIOAVAILABILITY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENZYME ACTIVITY; HUMAN; HYPERMENORRHEA; IN VITRO STUDY; METASTASIS; NAUSEA; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PANCREAS CANCER; POLLUTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PRURITUS; REVIEW; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTINEOPLASTIC AGENTS; CHEMORADIOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FATTY ACIDS, OMEGA-3; HUMANS; NEOPLASM METASTASIS; TUMOR MARKERS, BIOLOGICAL;

EID: 83555176443     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.233718     Document Type: Review

References (138)

1. Burdge G. Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. Curr Opin Clin Nutr Metab Care 2004;7:137-44. (Pubitemid 40340675)
2. Smith WL. Cyclooxygenases, peroxide tone and the allure of fish oil. Curr Opin Cell Biol 2005;17:174-82. (Pubitemid 40380941)
3. Hyde CA, Missailidis S. Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis. Int Immunopharmacol 2009;9:701-15.
4. Chapkin RS, McMurray DN, Lupton JR. Colon cancer, fatty acids and anti-inflammatory compounds. Curr Opin Gastroenterol 2007;23:48-54. (Pubitemid 44875910)
5. Roth EM, Harris WS. Fish oil for primary and secondary prevention of coronary heart disease. Curr Atheroscler Rep 2010;12:66-72.
6. Saravanan P, Davidson NC, Schmidt EB, et al. Cardiovascular effects of marine omega-3 fatty acids. Lancet 2010;376:540-50.
7. Fetterman JW Jr, Zdanowicz MM. Therapeutic potential of n-3 polyunsaturated fatty acids in disease. Am J Health Syst Pharm 2009;66:1169-79.
8. Calviello G, Serini S, Piccioni E. n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved. Curr Med Chem 2007;14:3059-69. (Pubitemid 350226957)
9. Hull MA, Ko SC, Hawcroft G. Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? Mol Cancer Ther 2004;3:1031-9. (Pubitemid 39199598)
10. Hawcroft G, Loadman PM, Belluzzi A, et al. Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signalling in human colorectal cancer cells. Neoplasia 2010;12:618-27.
11. Yang P, Chan D, Felix E, et al. Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells. J Lipid Res 2004;45:1030-9. (Pubitemid 38679498)
12. Vanamala J, Glagolenko A, Yang P, et al. Dietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPAR delta/PGE(2) and elevation of PGE(3). Carcinogenesis 2008;29:790-6. (Pubitemid 351494167)
13. Vecchio AJ, Simmons DM, Malkowski MG. Structural basis of fatty acid substrate binding to cyclooxygenase-2. J Biol Chem 2010;285:22152-63.
14. Yaqoob P. The nutritional significance of lipid rafts. Annu Rev Nutr 2009;29:257-82.
15. Schley PD, Brindley DN, Field CJ. (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J Nutr 2007;137:548-53. (Pubitemid 46397481)
16. Chapkin RS, Hong MY, Fan YY, et al. Dietary n-3 PUFA alter colonocyte mitochondrial membrane composition and function. Lipids 2002;37:193-9. (Pubitemid 34213986)
17. Collett ED, Davidson LA, Fan YY, et al. n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am J Physiol Cell Physiol 2001;280: C1066-75.
18. Simon HU, Haj-Yehia A, Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000;5:415-18. (Pubitemid 32162623)
19. Chang WL, Chapkin RS, Lupton JR. Fish oil blocks azoxymethane-induced rat colon tumorigenesis by increasing cell differentiation and apoptosis rather than decreasing cell proliferation. J Nutr 1998;128:491-7. (Pubitemid 28188343)
20. Crim KC, Sanders LM, Hong MY, et al. Upregulation of p21Waf1/ Cip1 expression in vivo by butyrate administration can be chemoprotective or chemopromotive depending on the lipid component of the diet. Carcinogenesis 2008;29:1415-20.
21. Sanders LM, Henderson CE, Hong MY, et al. An increase in reactive oxygen species by dietary fish oil coupled with the attenuation of antioxidant defenses by dietary pectin enhances rat colonocyte apoptosis. J Nutr 2004;134:3233-8. (Pubitemid 39602991)
22. Kolar SS, Barhoumi R, Callaway ES, et al. Synergy between docosahexaenoic acid and butyrate elicits p53-independent apoptosis via mitochondrial Ca(2+) accumulation in colonocytes. Am J Physiol Gastrointest Liver Physiol 2007;293:G935-43. (Pubitemid 350106557)
23. Kolar SS, Barhoumi R, Lupton JR, et al. Docosahexaenoic acid and butyrate synergistically induce colonocyte apoptosis by enhancing mitochondrial Ca2+ accumulation. Cancer Res 2007;67:5561-8. (Pubitemid 46997299)
24. Ng Y, Barhoumi R, Tjalkens RB, et al. The role of docosahexaenoic acid in mediating mitochondrial membrane lipid oxidation and apoptosis in colonocytes. Carcinogenesis 2005;26:1914-21. (Pubitemid 41631264)
25. Buchanan FG, Wang D, Bargiacchi F, et al. Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J Biol Chem 2003;278:35451-7. (Pubitemid 37102315)
26. Jump DB. Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 2004;41:41-78. (Pubitemid 38299789)
27. Serhan CN, Arita M, Hong S, et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004;39:1125-32. (Pubitemid 40129055)
28. Arita M, Bianchini F, Aliberti J, et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med. 2005;201:713-22. (Pubitemid 40395117)
29. Oh SF, Pillai PS, Recchiuti A, et al. Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. J Clin Invest 2011;121:569-81.
30. Arita M, Clish CB, Serhan CN. The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids. Biochem Biophys Res Commun 2005;338:149-57. (Pubitemid 41540550)
31. Hong S, Gronert K, Devchand PR, et al. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem 2003;278:14677-87. (Pubitemid 36799790)
32. Serhan CN, Yang R, Martinod K, et al. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med 2009;206:15-23.
33. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008;8:349-61. (Pubitemid 351595216)
34. Campbell EL, MacManus CF, Kominsky DJ, et al. Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification. Proc Natl Acad Sci U S A 2010;107:14298-303.
35. Clevers H. At the crossroads of inflammation and cancer. Cell 2004;118:671-4. (Pubitemid 39221727)
36. Calder PC. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2007;77:327-35. (Pubitemid 350198856)
37. Szymczak M, Murray M, Petrovic N. Modulation of angiogenesis by omega-3 polyunsaturated fatty acids is mediated by cyclooxygenases. Blood 2008;111:3514-21.
38. Tsuzuki T, Shibata A, Kawakami Y, et al. Conjugated eicosapentaenoic acid inhibits vascular endothelial growth factorinduced angiogenesis by suppressing the migration of human umbilical vein endothelial cells. J Nutr 2007;137:641-6. (Pubitemid 46397496)
39. Byers T. Nutrition and cancer among American Indians and Alaska Natives. Cancer 1996;78:1612-16. (Pubitemid 26317899)
40. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. American Institute of Cancer Research (AICR), Washington, DC: 2007.
41. Geelen A, Schouten JM, Kamphuis C, et al. Fish consumption, n-3 fatty acids, and colorectal cancer: a meta-analysis of prospective cohort studies. Am J Epidemiol 2007;166:1116-25. (Pubitemid 350022754)
42. Kim S, Sandler DP, Galanko J, et al. Intake of polyunsaturated fatty acids and distal large bowel cancer risk in whites and African Americans. Am J Epidemiol 2010;171:969-79.
43. Pot GK, Geelen A, van Heijningen EM, et al. Opposing associations of serum n-3 and n-6 polyunsaturated fatty acids with colorectal adenoma risk: an endoscopy-based case-control study. Int J Cancer 2008;123:1974-7.
44. Nelson RL, Tanure JC, Andrianopoulos G, et al. A comparison of dietary fish oil and corn oil in experimental colorectal carcinogenesis. Nutr Cancer 1988;11:215-20.
45. Minoura T, Takata T, Sakaguchi M, et al. Effect of dietary eicosapentaenoic acid on azoxymethane-induced colon carcinogenesis in rats. Cancer Res 1988;48:4790-4.
46. Reddy BS, Sugie S. Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res 1988;48:6642-7. (Pubitemid 19012181)
47. Deschner EE, Lytle JS, Wong G, et al. The effect of dietary omega-3 fatty acids (fish oil) on azoxymethanol-induced focal areas of dysplasia and colon tumor incidence. Cancer 1990;66:2350-6.
48. Reddy BS, Burill C, Rigotty J. Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res 1991;51:487-91.
49. Takahashi M, Minamoto T, Yamashita N, et al. Reduction in formation and growth of 1,2-dimethylhydrazine-induced aberrant crypt foci in rat colon by docosahexaenoic acid. Cancer Res 1993;53:2786-9. (Pubitemid 23180516)
50. Hendrickse CW, Keighley MR, Neoptolemos JP. Dietary omega-3 fats reduce proliferation and tumor yields at colorectal anastomosis in rats. Gastroenterology 1995;109:431-9.
51. Takahashi M, Fukutake M, Isoi T, et al. Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA). Carcinogenesis 1997;18:1337-42. (Pubitemid 28134706)
52. Good CK, Lasko CM, Adam J, et al. Diverse effect of fish oil on the growth of aberrant crypt foci and tumor multiplicity in F344 rats. Nutr Cancer 1998;31:204-11. (Pubitemid 28481855)
53. Singh J, Hamid R, Reddy BS. Dietary fish oil inhibits the expression of farnesyl protein transferase and colon tumor development in rodents. Carcinogenesis 1998;19:985-9. (Pubitemid 28375392)
54. Latham P, Lund EK, Johnson IT. Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon. Carcinogenesis 1999;20:645-50. (Pubitemid 29151302)
55. Rao CV, Hirose Y, Indranie C, et al. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 2001;61:1927-33. (Pubitemid 32692009)
56. Moreira AP, Sabarense CM, Dias CM, et al. Fish oil ingestion reduces the number of aberrant crypt foci and adenoma in 1,2-dimethylhydrazine-induced colon cancer in rats. Braz J Med Biol Res 2009;42:1167-72.
57. Woodworth HL, McCaskey SJ, Duriancik DM, et al. Dietary fish oil alters T lymphocyte cell populations and exacerbates disease in a mouse model of inflammatory colitis. Cancer Res 2010;70:7960-9.
58. Oshima M, Takahashi M, Oshima H, et al. Effects of docosahexaenoic acid (DHA) on intestinal polyp development in Apc delta 716 knockout mice. Carcinogenesis 1995;16:2605-7.
59. Paulsen JE, Elvsaas IK, Steffensen IL, et al. A fish oil derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl ester suppresses the formation and growth of intestinal polyps in the Min mouse. Carcinogenesis 1997;18:1905-10. (Pubitemid 28132373)
60. Petrik MBH, McEntee MF, Johnson BT, et al. Highly unsaturated (n-3) fatty acids, but not alpha-linolenic, conjugated linoleic or gamma-linolenic acids, reduce tumorigenesis in Apc(Min/+) mice. J Nutr 2000;130:2434-43.
61. Petrik MBH, McEntee MF, Chiu CH, et al. Antagonism of arachidonic acid is linked to the antitumorigenic effect of dietary eicosapentaenoic acid in Apc(Min/+) mice. J Nutr 2000;130:1153-8. (Pubitemid 30233261)
62. Bose M, Hao X, Ju J, et al. Inhibition of tumorigenesis in ApcMin/+ mice by a combination of (-)-epigallocatechin-3- gallate and fish oil. J Agric Food Chem 2007;55:7695-700. (Pubitemid 47522174)
63. Fini L, Piazzi G, Ceccarelli C, et al. Highly purified eicosapentaenoic acid as free fatty acids strongly suppresses polyps in Apc (Min/+) mice. Clin Cancer Res 2010;16:5703-11.
64. West NJ, Belluzzi A, Lund EK, et al. Eicosapentaenoic acid (EPA), as the free fatty acid, reduces colonic crypt cell proliferation in patients with sporadic colorectal polyps. Gut 2009;58:A68.
65. Mund RC, Pizato N, Bonatto S, et al. Decreased tumor growth in Walker 256 tumor-bearing rats chronically supplemented with fish oil involves COX-2 and PGE2 reduction associated with apoptosis and increased peroxidation. Prostaglandins Leukot Essent Fatty Acids 2007;76:113-20. (Pubitemid 46217230)
66. Davidson LA, Nguyen DV, Hokanson RM, et al. Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res 2004;64:6797-804. (Pubitemid 39297944)
67. Boudreau MD, Sohn KH, Rhee SH, et al. Suppression of tumor cell growth both in nude mice and in culture by n-3 polyunsaturated fatty acids: mediation through cyclooxygenase-independent pathways. Cancer Res 2001;61:1386-91. (Pubitemid 34292561)
68. Clarke RG, Lund EK, Latham P, et al. Effect of eicosapentaenoic acid on the proliferation and incidence of apoptosis in the colorectal cell line HT29. Lipids 1999;34:1287-95. (Pubitemid 30044267)
69. Llor X, Pons E, Roca A, et al. The effects of fish oil, olive oil, oleic acid and linoleic acid on colorectal neoplastic processes. Clin Nutr 2003;22:71-9. (Pubitemid 36193183)
70. Tsai WS, Nagawa H, Kaizaki S, et al. Inhibitory effects of n-3 polyunsaturated fatty acids on sigmoid colon cancer transformants. J Gastroenterol 1998;33:206-12. (Pubitemid 28143398)
71. Calviello G, Di Nicuolo F, Gragnoli S, et al. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis 2004;25:2303-10. (Pubitemid 39625169)
72. Chen ZY, Istfan NW. Docosahexaenoic acid is a potent inducer of apoptosis in HT-29 colon cancer cells. Prostaglandins Leukot Essent Fatty Acids 2000;63:301-8.
73. Mengeaud V, Nano JL, Fournel S, et al. Effects of eicosapentaenoic acid, gamma-linolenic acid and prostaglandin E1 on three human colon carcinoma cell lines. Prostaglandins Leukot Essent Fatty Acids 1992;47:313-19.
74. Palozza P, Calviello G, Maggiano N, et al. Beta-carotene antagonizes the effects of eicosapentaenoic acid on cell growth and lipid peroxidation in WiDr adenocarcinoma cells. Free Radic Biol Med 2000;28:228-34. (Pubitemid 30084015)
75. Calviello G, Resci F, Serini S, et al. Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2. Carcinogenesis 2007;28:1202-9. (Pubitemid 47062678)
76. Lee SA, Kim HJ, Chang KC, et al. DHA and EPA Down-regulate COX-2 Expression through Suppression of NF-kappaB Activity in LPS-treated Human Umbilical Vein Endothelial Cells. Korean J Physiol Pharmacol 2009;13:301-7.
77. Paulsen JE, Stamm T, Alexander J. A fish oil-derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl esters inhibits the formation and growth of aberrant crypt foci in rat colon. Pharmacol Toxicol 1998;82:28-33. (Pubitemid 28066612)
78. Cannizzo F Jr, Broitman SA. Postpromotional effects of dietary marine or safflower oils on large bowel or pulmonary implants of CT-26 in mice. Cancer Res 1989;49:4289-94. (Pubitemid 19207274)
79. Iigo M, Nakagawa T, Ishikawa C, et al. Inhibitory effects of docosahexaenoic acid on colon carcinoma 26 metastasis to the lung. Br J Cancer 1997;75:650-5. (Pubitemid 27091076)
80. Calder PC, Davis J, Yaqoob P, et al. Dietary fish oil suppresses human colon tumour growth in athymic mice. Clin Sci 1998;94:303-11. (Pubitemid 28118993)
81. Kato T, Hancock RL, Mohammadpour H, et al. Influence of omega-3 fatty acids on the growth of human colon carcinoma in nude mice. Cancer Lett 2002;187:169-77. (Pubitemid 35279346)
82. Togni V, Ota CCC, Folador A, et al. Cancer cachexia and tumor growth reduction in Walker 256 tumor-bearing rats supplemented with N-3 polyunsaturated fatty acids for one generation. Nutr Cancer 2003;46:52-8. (Pubitemid 37163291)
83. Tsuzuki T, Igarashi M, Miyazawa T. Conjugated eicosapentaenoic acid (EPA) inhibits transplanted tumor growth via membrane lipid peroxidation in nude mice. J Nutr 2004;134:1162-6. (Pubitemid 38619957)
84. Pizato N, Bonatto S, Yamazaki RK, et al. Ratio of n6 to n-3 fatty acids in the diet affects tumor growth and cachexia in Walker 256 tumor-bearing rats. Nutr Cancer 2005;53:194-201.
85. Iwamoto S, Senzaki H, Kiyozuka Y, et al. Effects of fatty acids on liver metastasis of ACL-15 rat colon cancer cells. Nutr Cancer 1998;31:143-50. (Pubitemid 28428076)
86. Gutt CN, Brinkmann L, Mehrabi A, et al. Dietary omega-3- polyunsaturated fatty acids prevent the development of metastases of colon carcinoma in rat liver. Eur J Nutr 2007;46:279-85. (Pubitemid 47125268)
87. Griffini P, Fehres O, Klieverik L, et al. Dietary omega-3 polyunsaturated fatty acids promote colon carcinoma metastasis in rat liver. Cancer Res 1998;58:3312-19. (Pubitemid 28371071)
88. Beckermann B, Beneke M, Seitz I. Comparative bioavailability of eicosapentaenoic acid and docasahexaenoic acid from triglycerides, free fatty acids and ethyl esters in volunteers. Arzneimittelforschung 1990;40:700-4. (Pubitemid 20199604)
89. Lawson LD, Hughes BG. Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters. Biochem Biophys Res Commun 1988;152:328-35.
90. Yang LY, Kuksis A, Myher JJ. Lipolysis of menhaden oil triacylglycerols and the corresponding fatty acid alkyl esters by pancreatic lipase in vitro: a reexamination. J Lipid Res 1990;31:137-47.
91. Ackman RG. The absorption of fish oils and concentrates. Lipids 1992;27:858-62.
92. Kim W, McMurray DN, Chapkin RS. n-3 polyunsaturated fatty acidsephysiological relevance of dose. Prostaglandins Leukot Essent Fatty Acids 2010;82:155-8.
93. Anti M, Marra G, Armelao F, et al. Effect of omega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. Gastroenterology 1992;103:883-91.
94. Bartoli GM, Palozza P, Marra G, et al. n-3 PUFA and alpha-tocopherol control of tumor cell proliferation. Mol Aspects Med 1993;14:247-52.
95. Bartram HP, Gostner A, Scheppach W, et al. Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2 release in healthy subjects. Gastroenterology 1993;105:1317-22. (Pubitemid 23315305)
96. Anti M, Armelao F, Marra G, et al. Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology 1994;107:1709-18. (Pubitemid 24357624)
97. Huang YC, Jessup JM, Forse RA, et al. n-3 fatty acids decrease colonic epithelial cell proliferation in high-risk bowel mucosa. Lipids 1996;31:S313-17.
98. Gee JM, Watson M, Matthew JA, et al. Consumption of fish oil leads to prompt incorporation of eicosapentaenoic acid into colonic mucosa of patients prior to surgery for colorectal cancer, but has no detectable effect on epithelial cytokinetics. J Nutr 1999;129:1862-5. (Pubitemid 29468600)
99. Cheng J, Ogawa K, Kuriki K, et al. Increased intake of n-3 polyunsaturated fatty acids elevates the level of apoptosis in the normal sigmoid colon of patients polypectomized for adenomas/ tumors. Cancer Lett 2003;193:17-24. (Pubitemid 36412075)
100. Courtney ED, Matthews S, Finlayson C, et al. Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Int J Colorectal Dis 2007;22:765-76. (Pubitemid 46863753)
101. Akedo I, Ishikawa H, Nakamura T, et al. Three cases with familial adenomatous polyposis diagnosed as having malignant lesions in the course of a long-term trial using docosahexanoic acid (DHA)-concentrated fish oil capsules. Jpn J Clin Oncol 1998;28:762-5. (Pubitemid 128525831)
102. West NJ, Clark SK, Phillips RK, et al. Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis. Gut 2010;59:918-25.
103. Gibney MJ, Hunter B. The effects of short- and long-term supplementation with fish oil on the incorporation of n-3 polyunsaturated fatty acids into cells of the immune system in healthy volunteers. Eur J Clin Nutr 1993;47:255-9. (Pubitemid 23111664)
104. Hillier K, Jewell R, Dorrell L, et al. Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. Gut 1991;32:1151-5.
105. GISSI. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999;354:447-55.
106. Bays H. Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids. Am J Cardiol 2006;98:71ie6i.
107. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747-57. (Pubitemid 35364932)
108. Leaf A, Jorgensen MB, Jacobs AK, et al. Do fish oils prevent restenosis after coronary angioplasty? Circulation 1994;90:2248-57. (Pubitemid 24354309)
109. Lien EL. Toxicology and safety of DHA. Prostaglandins Leukot Essent Fatty Acids 2009;81:125-32.
110. Dyerberg J, Bang HO, Stoffersen E, et al. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978;2:117-19. (Pubitemid 8373454)
111. Harris WS. Expert opinion: omega-3 fatty acids and bleeding-cause for concern? Am J Cardiol 2007;99:44Ce6C.
112. Foran SE, Flood JG, Lewandrowski KB. Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish? Arch Pathol Lab Med 2003;127:1603-5. (Pubitemid 37517473)
113. Steinbach G, Lynch PM, Phillips RK, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946-52. (Pubitemid 30419089)
114. Calviello G, Di Nicuolo F, Serini S, et al. Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5- fluorouracil. Cancer Chemother Pharmacol 2005;55:12-20. (Pubitemid 40064491)
115. Jordan A, Stein J. Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2. Eur J Nutr 2003;42:324-31. (Pubitemid 38055612)
116. Wynter MP, Russell ST, Tisdale MJ. Effect of n-3 fatty acids on the antitumour effects of cytotoxic drugs. In Vivo 2004;18:543-7.
117. Calviello G, Serini S, Piccioni E, et al. Antineoplastic effects of n-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies. Nutr Cancer 2009;61:287-301.
118. Bougnoux P, Hajjaji N, Ferrasson MN, et al. Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br J Cancer 2009;101:1978-85.
119. Benais-Pont G, Dupertuis YM, Kossovsky MP, et al. Omega-3 polyunsaturated fatty acids and ionizing radiation: combined cytotoxicity on human colorectal adenocarcinoma cells. Nutrition 2006;22:931-9. (Pubitemid 44234013)
120. Gramaglia A, Loi GF, Mongioj V, et al. Increased survival in brain metastatic patients treated with stereotactic radiotherapy, omega three fatty acids and bioflavonoids. Anticancer Res 1999;19:5583-6. (Pubitemid 30093332)
121. Minami Y, Miyata H, Doki Y, et al. omega-3 Fatty acid-containing diet (Racol) reduces toxicity of chemoradiation therapy for patients with esophageal cancer. Gan To Kagaku Ryoho 2008;35:437-40.
122. Dewey A, Baughan C, Dean T, et al. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev 2007;(4): CD004597.
123. Fearon KC, Von Meyenfeldt MF, Moses AG, et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 2003;52:1479-86. (Pubitemid 37176729)
124. Gogos CA, Ginopoulos P, Salsa B, et al. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer 1998;82:395-402. (Pubitemid 28060258)
125. Jatoi A, Rowland K, Loprinzi CL, et al. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 2004;22:2469-76. (Pubitemid 41115406)
126. Colomer R, Moreno-Nogueira JM, Garcia-Luna PP, et al. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 2007;97:823-31. (Pubitemid 46554396)
127. Read JA, Beale PJ, Volker DH, et al. Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer 2007;15:301-7. (Pubitemid 46295216)
128. Ryan AM, Reynolds JV, Healy L, et al. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg 2009;249:355-63.
129. Bonilla DL, Fan YY, Chapkin RS, et al. Transgenic mice enriched in omega-3 fatty acids are more susceptible to pulmonary tuberculosis: impaired resistance to tuberculosis in fat-1 mice. J Infect Dis 2010;201:399-408.
130. McFarland CT, Fan YY, Chapkin RS, et al. Dietary polyunsaturated fatty acids modulate resistance to Mycobacterium tuberculosis in guinea pigs. J Nutr 2008;138:2123-8.
131. Anderson M, Fritsche KL. (n-3) Fatty acids and infectious disease resistance. J Nutr 2002;132:3566-76. (Pubitemid 35435030)
132. Jordao L, Lengeling A, Bordat Y, et al. Effects of omega-3 and -6 fatty acids on Mycobacterium tuberculosis in macrophages and in mice. Microbes Infect 2008;10:1379-86.
133. Pierre M, Husson MO, Le Berre R, et al. Omega-3 polyunsaturated fatty acids improve host response in chronic Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 2007;292:L1422-31. (Pubitemid 47077358)
134. Saini A, Harjai K, Chhibber S. Sea-cod oil supplementation alters the course of Streptococcus pneumoniae infection in BALB/c mice. Eur J Clin Microbiol Infect Dis 2011;30:393-400.
135. Tiesset H, Pierre M, Desseyn JL, et al. Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro- and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection. J Nutr 2009;139:82-9.
136. Alperovich M, Neuman MI, Willett WC, et al. Fatty acid intake and the risk of community-acquired pneumonia in U.S. women. Nutrition 2007;23:196-202. (Pubitemid 46367565)
137. Merchant AT, Curhan GC, Rimm EB, et al. Intake of n-6 and n-3 fatty acids and fish and risk of community-acquired pneumonia in US men. Am J Clin Nutr 2005;82:668-74.
138. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006;83:1467S-76S. (Pubitemid 44713087)